
Diclivo AQ 75mg Injection
Marketer
Medfence Labs
Salt Composition
Diclofenac (75mg)
Overview Diclivo AQ 75mg Injection
A single 75mg dose of Diclivo AQ Injection provides pain relief. This injectable medication targets pain, inflammation, stiffness, and joint discomfort associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma. Parenteral administration is indicated when oral intake is infeasible. Always receive this injection from a qualified healthcare provider; self-injection is strictly prohibited. Prior heart conditions or stroke history should be disclosed to your physician. Report any injection site reactions (pain, swelling, redness) immediately. Common adverse effects include nausea, vomiting, headache, and local injection site reactions. For extended therapy, your doctor may monitor kidney and liver function, as well as key blood parameters. Prolonged use carries potential risks, including gastrointestinal bleeding and renal complications.
Uses of Diclivo AQ 75mg Injection
Analgesia
Major Benefits of Diclivo AQ 75mg Injection:
Administering this medication will be handled by your physician or their qualified nurse; self-medication is strictly prohibited.
Common Side effects of Diclivo AQ 75mg Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Diclivo AQ 75mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Diclivo AQ 75mg Injection works:
Diclivo AQ 75mg Injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and the associated signs of inflammation, such as redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Diclivo AQ 75mg Injection concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Administering Diclivo AQ 75mg Injection to pregnant individuals poses a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Diclivo AQ 75mg Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Administering Diclivo AQ 75mg Injection may result in adverse reactions that impair driving capabilities.
KidneyCAUTION
For individuals with impaired kidney function, administration of Diclivo AQ 75mg Injection requires careful monitoring. Dosage modification of Diclivo AQ 75mg Injection may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Diclivo AQ 75mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Diclivo AQ 75mg Injection :
Omit a Diclivo AQ 75mg Injection dose? Seek medical advice.
Facts to Know About Diclivo AQ 75mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylacetic acid derivative |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
